| Jeanne Tuttle, RPH | |
|
810 Vermont Ave Nw, Washington, DC 20420-0001 | |
| (202) 306-9980 | |
| Not Available |
| Full Name | Jeanne Tuttle |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 810 Vermont Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225110240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP030860L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeanne Tuttle, RPH 371 Carlisle Dr, Avondale, PA 19311-1440 Ph: () - | Jeanne Tuttle, RPH 810 Vermont Ave Nw, Washington, DC 20420-0001 Ph: (202) 306-9980 |
News Archive
A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells.
Scientists at King's College London and the National Diabetes Centre (Sri Lanka) have found evidence of a high number of risk factors for type 2 diabetes among the young urban population in Sri Lanka. The study is the first large-scale investigation into diabetes risk among children and young people in South Asia, and provides further evidence that the region is rapidly becoming a hotspot in the growing international diabetes epidemic.
It is known from previous research that the ER-beta estrogen receptor often has a protective effect. A new study from Lund University in Sweden has found that this effect is more pronounced in patients that undergo chemotherapy.
Jobs that are both challenging and afford opportunities to take responsibility seem to protect against the development of dementia, concludes research in Occupational and Environmental Medicine.
Boston Scientific Europe announced the launch of the RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems in Europe, a new family of devices featuring SmartCRT technology, which recently received CE Mark and are now available for heart failure patients across Europe.
› Verified 9 days ago
Juliana O Anamelechi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000 | |
Reine Kamtcheu Lienou, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 | |
Gina Jin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-4080 | |
Dr. Bruce Cofane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 845 Bladensburg Rd Ne, Washington, DC 20002 Phone: 202-397-2600 | |
Mesay Abebe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 14th St Nw, Washington, DC 20010 Phone: 202-777-3774 | |
Dr. Salome K Bwayo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 4th St Nw, Washington, DC 20059 Phone: 202-806-7262 Fax: 202-806-4478 | |
Tracy Doney, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Rm B147, Washington, DC 20010 Phone: 202-877-6747 |